Masakazu Tanaka Selected Research

2- butyl- 3- ((2'- (1H- tetrazol- 5- yl)biphenyl- 4- yl)methyl)- 3H- imidazo(4,5- b)pyridine

9/2004

Effects of angiotensin II type 1 receptor antagonist on smooth muscle cell phenotype in intramyocardial arteries from spontaneously hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masakazu Tanaka Research Topics

Disease

5	Neoplasms (Cancer) 03/2022 - 05/2008
5	Infections 01/2020 - 07/2002
5	Hypertension (High Blood Pressure) 03/2006 - 09/2004
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2013
4	Stroke (Strokes) 03/2006 - 11/2004
4	Fibrosis (Cirrhosis) 01/2005 - 05/2002
3	T-Cell Leukemia (Leukemia, T Cell) 01/2021 - 05/2008
3	Vascular Remodeling 01/2005 - 09/2004
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 08/2016
2	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 11/2014
2	Cholangiocarcinoma 06/2014 - 12/2013
2	Inflammation (Inflammations) 12/2013 - 05/2003
2	Atherosclerosis 01/2011 - 05/2002
2	Hypercholesterolemia 11/2006 - 05/2002
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2005 - 11/2004
1	Aneuploidy (Aneuploid) 03/2022
1	Hypertriglyceridemia 01/2021
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2020
1	Tumor Virus Infections (Shope Fibroma) 05/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Hemorrhage 01/2018
1	Disseminated Intravascular Coagulation 01/2018
1	Carcinoma (Carcinomatosis) 12/2017
1	Alzheimer Disease (Alzheimer's Disease) 08/2016
1	Central Nervous System Diseases (CNS Diseases) 08/2016
1	Weight Gain 04/2016
1	Chromosomal Instability (Chromosome Stability) 02/2016
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2016
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2012
1	Dyslipidemias (Dyslipidemia) 01/2011
1	Lymphoma (Lymphomas) 08/2009
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 05/2008

Drug/Important Bio-Agent (IBA)

5	EnzymesIBA 01/2021 - 05/2003
4	Biomarkers (Surrogate Marker)IBA 12/2017 - 06/2014
4	Polysaccharides (Glycans)IBA 12/2017 - 11/2014
4	Proteins (Proteins, Gene)FDA Link 12/2013 - 08/2009
4	Nitric Oxide Synthase (NO Synthase)IBA 01/2005 - 05/2002
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2022 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 12/2013 - 07/2002
3	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2005 - 05/2002
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2005 - 09/2004
2	Pharmaceutical PreparationsIBA 08/2016 - 05/2002
2	Poly Adenosine Diphosphate RiboseIBA 02/2016 - 12/2013
2	AntioxidantsIBA 01/2011 - 05/2002
2	Probucol (Lorelco)FDA Link 11/2006 - 05/2002
2	Superoxide Dismutase-1IBA 11/2006 - 11/2004
2	Amlodipine (Norvasc)FDA LinkGeneric 03/2006 - 11/2004
2	Enalapril FDA LinkGeneric 03/2006 - 09/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2005 - 01/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2005 - 09/2004
2	Angiotensin IIIBA 01/2005 - 09/2004
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2005 - 05/2002
2	Superoxides (Superoxide)IBA 11/2004 - 05/2002
2	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2004 - 05/2002
1	3-aminobenzamideIBA 03/2022
1	MetalsIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Cell-Penetrating PeptidesIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	MutagensIBA 05/2019
1	olaparibIBA 01/2019
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2019
1	EdaravoneIBA 09/2018
1	Liposomes (Liposome)IBA 09/2018
1	ThrombomodulinIBA 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	Hemostatics (Antihemorrhagics)IBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	BilirubinIBA 01/2016
1	Taxoids (Taxanes)IBA 11/2014
1	AndrogensIBA 11/2014
1	Abiraterone AcetateIBA 11/2014
1	cabazitaxel FDA Link 11/2014
1	SugarsIBA 06/2014
1	Blood Proteins (Serum Proteins)IBA 06/2014
1	8-hydroxyguanineIBA 12/2013
1	X-ray Repair Cross Complementing Protein 1IBA 12/2013
1	Glutathione (Reduced Glutathione)IBA 12/2013
1	TransferasesIBA 12/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Methylnitronitrosoguanidine (MNNG)IBA 02/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011
1	Eicosapentaenoic AcidIBA 01/2011
1	Neuraminidase (Sialidase)IBA 02/2010
1	NF-kappa B (NF-kB)IBA 05/2008
1	Phosphotransferases (Kinase)IBA 05/2008
1	pitavastatin (itavastatin)FDA Link 11/2006
1	PPAR gammaIBA 11/2006
1	CilazaprilIBA 01/2005

Therapy/Procedure

4	Therapeutics 03/2022 - 01/2011
1	Stents 01/2021
1	Percutaneous Coronary Intervention 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2018
1	Castration 11/2014